UCB received Japanese approval for two self-administration methods for Rystiggo (anti-FcRn) in generalised myasthenia gravis (gMG), allowing patients to use an infusion pump or manual syringe at home after training. To support the label expansion, UCB also launched a home delivery service in Japan to enhance patient convenience and satisfaction. The move aligns with Rystiggo's self-administration approval in the EU earlier this year and could support its positioning amid growing competition. We ...
The ongoing tariff war continues to create uncertainty for investors, with a trade embargo between the US and China. Although Europe has received a temporary reprieve, the prolonged situation could result in significant economic damage. We are maintaining a defensive stance in our Benelux Dynamic Top Pick List, as the Federal Reserve holds steady and the European Central Bank may continue lowering rates. Pessimism regarding the European industry has increased, though some US-based European compa...
In this note we lower our organic growth, gross profit margin expectations and increase OpEx expectations, which results in an estimated adj. EBITA of € 471m for FY25e or 8.1% below our prior estimate. We provide a detailed overview for each region on a quarterly basis. Furthermore, we compare the organic growth dynamics between Azelis and IMCD. Azelis is trading at a very attractive valuation not only compared to IMCD but also to the broader market. The recent market developments drive a lower ...
Ageas reports on the progress of share buy-back programme Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 18,241 Ageas shares in the period from 28-04-2025 until 02-05-2025. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)28-04-20254,620250,08054.1753.8554.6529-04-20254,566250,08854.8154.6055.0030-04-20254,542250,06355.0754.8555.2501-05-2025-----02-05-20254,513250,06655.4155.2555.60Total18,2411,000,29754.8453.8555.60 Since...
Rapport d’Ageas sur le programme de rachat d’actions Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 18.241 actions Ageas ont été achetées durant la période du 28-04-2025 au 02-05-2025. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)28-04-20254.620250.08054,1753,8554,6529-04-20254.566250.08854,8154,6055,0030-04-20254.542250.06355,0754,8555,2501-05-2025-----02-05-20254.513250.06655,4155,2555,60Total18.2411.000.29754,8453,8555,60 Depuis le lance...
Rapport d’Ageas sur le programme de rachat d’actions Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 18.241 eigen aandelen ingekocht werden tussen 28-04-2025 en 02-05-2025. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)28-04-20254.620250.08054,1753,8554,6529-04-20254.566250.08854,8154,6055,0030-04-20254.542250.06355,0754,8555,2501-05-2025-----02-05-20254.513250.06655,4155,2555,60Totaal18.2411.000.29754,8453,8555,60 Vanaf d...
Ageas reports on the progress of share buy-back programme Further to the initiation of the share buy-back programme announced on 28 August 2024, Ageas reports the purchase of 21,383 Ageas shares in the period from 21-04-2025 until 25-04-2025. DateNumber ofSharesTotal amount(EUR)Average price(EUR)Lowest price(EUR)Highest price(EUR)21-04-2025-----22-04-20256,217330,01953.0852.9053.2523-04-20254,674250,06053.5053.2553.9024-04-20255,842314,58853.8553.6053.9525-04-20254,650250,06453.7853.6053.95Total21,3831,144,73053.5352.9053.95 Since the start of the share buy-back programme on 16 September 20...
Rapport d’Ageas sur le programme de rachat d’actions Dans le cadre du programme de rachat d’actions annoncé le 28 août 2024, Ageas indique que 21.383 actions Ageas ont été achetées durant la période du 21-04-2025 au 25-04-2025. DateNombred’actionsMontant total(EUR)Cours moyen(EUR)Cours le plus bas (EUR)Cours le plus élevé (EUR)21-04-2025-----22-04-20256.217330.01953,0852,9053,2523-04-20254.674250.06053,5053,2553,9024-04-20255.842314.58853,8553,6053,9525-04-20254.650250.06453,7853,6053,95Total21.3831.144.73053,5352,9053,95 Depuis le lancement du programme de rachat d’actions le 16 septembre ...
Ageas rapporteert over de inkoop van eigen aandelen Naar aanleiding van het aandelen-inkoopprogramma dat op 28 augustus 2024 aangekondigd werd, maakt Ageas bekend dat er 21.383 eigen aandelen ingekocht werden tussen 21-04-2025 en 25-04-2025. DatumAantalaandelenTotaal Bedrag(EUR)Gemiddelde koers(EUR)Laagste koers(EUR)Hoogste koers(EUR)21-04-2025-----22-04-20256.217330.01953,0852,9053,2523-04-20254.674250.06053,5053,2553,9024-04-20255.842314.58853,8553,6053,9525-04-20254.650250.06453,7853,6053,95Totaal21.3831.144.73053,5352,9053,95 Vanaf de start van het aandelen-inkoopprogramma op 16 septemb...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.